Skip to search formSkip to main contentSkip to account menu

KAF156

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

ImidazolesPiperazines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
OC 8721 WANECAM II – A CLINICAL TRIAL PROGRAMME TO ASSESS SAFETY, EFFICACY AND TRANSMISSION-BLOCKING PROPERTIES OF A NEW ANTIMALARIAL KAF156 (GANAPLACIDE) IN UNCOMPLICATED MALARIA IN WEST AND CENTRAL…
Background Despite major progress in the past decade, malaria remains a major public health problem in sub-Saharan Africa. West… 
2016
2016
KAF156, a New Antimalarial, Active and Safe in Small Trial
Because of increasing resistance of malaria parasites to artemisinin and partner drugs, especially in Southeast Asia, new… 
2014
2014
A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the antimalarial agents KAE609 and piperaquine (PPQ)
Background KAF156 is a novel imidazolopiperazine anti-malarial with activity against pre-erythrocytic liver stages, asexual and… 
2014
2014
Disease Transmission Prophylaxis, Treatment, and Prevention of Candidate with Potential for Use in KAF156 Is an Antimalarial Clinical
Antimicrob. Agents Chemother.€2014, 58(9):5060. DOI:Thierry T. DiaganaSauerwein, Elizabeth A. Winzeler, Richard J. Glynne and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)